Editorial: Novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantation

Editorial: Novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantation

Bibliographic Details
Main Authors:	Yao Sun, Xiaohui Zhang, Liangding Hu, Muhammad Bilal Abid
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-07-01
Series:	Frontiers in Immunology
Subjects:	allogeneic stem cell transplant acute leukemia chimeric antigen receptor IFN-a lenalidomide graft-versus-host-disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1248270/full

Similar Items

Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation
by: Motoko Koyama, et al.
Published: (2021-09-01)

Graft‐versus‐host disease after autologous stem cell transplantation in a recipient who underwent allogeneic stem cell transplantation 20 years earlier
by: Osamu Imataki, et al.
Published: (2024-04-01)

Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant
by: Pengjiang Liu, et al.
Published: (2020-09-01)

Allogeneic Stem Cell Transplantation in Multiple Myeloma
by: Christine Greil, et al.
Published: (2021-12-01)

Comparison of Post-transplant Cyclophosphamide Containing Immunosuppressive Regimen with Standard Immunosuppressive Regimen in Allogeneic Stem Cell Transplantation from Matched Sibling Donor
by: Osman KARA, et al.
Published: (2021-12-01)

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
by: Michael Stadler, et al.
Published: (2022-08-01)

Early administration of lenalidomide after allogeneic hematopoietic stem cell transplantation suppresses graft‐versus‐host disease by inhibiting T‐cell migration to the gastrointestinal tract
by: Yukie Tsubokura, et al.
Published: (2022-09-01)

Alterations of Peripheral Blood T Cell Subsets following Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation
by: Ann-Kristin Schmaelter, et al.
Published: (2021-11-01)

Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
by: Nidhi Sharma, et al.
Published: (2021-02-01)

Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
by: Linlu Tian, et al.
Published: (2022-08-01)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
by: Natalie Köhler, et al.
Published: (2021-03-01)

Incidence of ocular manifestations in patients with graft versus host disease after allogeneic stem cell transplant in Riyadh, Saudi Arabia
by: Tariq Aldebasi, et al.
Published: (2022-07-01)

Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation
by: Dionysios Vythoulkas, et al.
Published: (2023-01-01)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
by: Grażyna Kaminska-Winciorek, et al.
Published: (2020-07-01)

CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
by: Hiroshi Takahashi, et al.
Published: (2015-01-01)

Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants
by: Maria Iacobescu, et al.
Published: (2024-02-01)

Clinical Aspects Of Sclerodermatous Type Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation
by: Yue Hu, et al.
Published: (2017-03-01)

DONOR CHIMERISM IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION
by: V. A. Lavrinenko, et al.
Published: (2018-07-01)

Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models
by: Yan Jiang, et al.
Published: (2023-12-01)

Cytomegalovirus Infection and Treatment in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from a Single Institution in an Endemic Area
by: Hsin - Chen Lin, et al.
Published: (2017-05-01)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: a Retrospective Study in a Single Center
by: Mei-Fang Hou, et al.
Published: (2015-03-01)

Correlation of mixed lymphocyte culture with chronic graft-versus-host disease following allogeneic stem cell transplantation
by: J.E.L. Visentainer, et al.
Published: (2002-05-01)

Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience
by: Justin Jiang, et al.
Published: (2022-11-01)

Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute Leukemia
by: Panagiotis Tsirigotis, et al.
Published: (2021-05-01)

Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation
by: Yuan Song, et al.
Published: (2020-10-01)

De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience
by: Yul Hee Cho, et al.
Published: (2013-09-01)

HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
by: Malte Roerden, et al.
Published: (2020-07-01)

How to Combine the Two Landmark Treatment Methods—Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia?
by: Mingming Zhang, et al.
Published: (2020-12-01)

Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation
by: Hideaki Fujiwara
Published: (2021-08-01)

Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease
by: Ying-Jun Chang, et al.
Published: (2018-12-01)

Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
by: Elisa Roldan, et al.
Published: (2019-09-01)

Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
by: Melissa Mavers, et al.
Published: (2017-07-01)

Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
by: Erika S Varady, et al.
Published: (2023-09-01)

Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma
by: Maiia V. Firsova, et al.
Published: (2021-07-01)

Impact of Blood Transfusion on Haematopoietic Stem Cell Transplantation Outcome
by: Nermeen Adel Nabih, et al.
Published: (2019-11-01)

The risk factors for cytomegalovirus reactivation following stem cell transplantation
by: Bahareh Valadkhani, et al.
Published: (2016-01-01)

A Case of Multiple Sclerosis—Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature
by: Joyutpal Das, et al.
Published: (2020-05-01)

Severe graft‐versus‐host disease post allogeneic hematopoietic stem cell transplantation due to loss of HLA heterozygosity in recipient lymphocytes after full graft rejection
by: Song Xue, et al.
Published: (2023-08-01)